|
|
|
|
Presentation of an Immunodominant Immediate-Early CD8+ T Cell Epitope Resists Human Cytomegalovirus Immunoevasion
|
|
|
|
|
|
|
|
نویسنده
|
ameres s. ,mautner j. ,schlott f. ,neuenhahn m. ,busch d.h. ,plachter b. ,moosmann a.
|
|
منبع
|
plos pathogens - 2013 - دوره : 9 - شماره : 5
|
|
چکیده
|
Control of human cytomegalovirus (hcmv) depends on cd8+ t cell responses that are shaped by an individual's repertoire of mhc molecules. mhc class i presentation is modulated by a set of hcmv-encoded proteins. here we show that hcmv immunoevasins differentially impair t cell recognition of epitopes from the same viral antigen,immediate-early 1 (ie-1),that are presented by different mhc class i allotypes. in the presence of immunoevasins,hla-a- and hla-b-restricted t cell clones were ineffective,but hla-c*0702-restricted t cell clones recognized and killed infected cells. resistance of hla-c*0702 to viral immunoevasins us2 and us11 was mediated by the alpha3 domain and c-terminal region of the hla heavy chain. in healthy donors,hla-c*0702-restricted t cells dominated the t cell response to ie-1. the same hla-c allotype specifically protected infected cells from attack by nk cells that expressed a corresponding hla-c-specific kir. thus,allotype-specific viral immunoevasion allows hcmv to escape control by nk cells and hla-a- and hla-b-restricted t cells,while the virus becomes selectively vulnerable to an immunodominant population of hla-c-restricted t cells. our work identifies a t cell population that may be of particular efficiency in hcmv-specific immunotherapy. © 2013 ameres et al.
|
|
|
|
|
آدرس
|
clinical cooperation group immunooncology,department of medicine iii,klinikum der universität münchen,department of gene vectors,helmholtz zentrum münchen,munich,germany,dzif - german center for infection research,munich, Germany, dzif - german center for infection research,munich,germany,clinical cooperation group pediatric tumor immunology,helmholtz zentrum münchen,and children's hospital,technische universität münchen,munich, Germany, dzif - german center for infection research,munich,germany,institute for medical microbiology,immunology and hygiene,technische universität münchen,munich,germany,clinical cooperation group immune monitoring,helmholtz zentrum münchen and technische universität münchen,munich, Germany, dzif - german center for infection research,munich,germany,institute for medical microbiology,immunology and hygiene,technische universität münchen,munich,germany,clinical cooperation group immune monitoring,helmholtz zentrum münchen and technische universität münchen,munich, Germany, dzif - german center for infection research,munich,germany,institute for medical microbiology,immunology and hygiene,technische universität münchen,munich,germany,clinical cooperation group immune monitoring,helmholtz zentrum münchen and technische universität münchen,munich, Germany, institute for virology,university medical center,johannes-gutenberg-universität mainz,mainz, Germany, clinical cooperation group immunooncology,department of medicine iii,klinikum der universität münchen,department of gene vectors,helmholtz zentrum münchen,munich,germany,dzif - german center for infection research,munich, Germany
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|